ERBB2 and breast carcinoma: Taken together, these data suggest that in breast cancer cell lines with low/absent PTPN13 expression, and high ErbB2 expression, EphrinB1 phosphorylation is elevated as is its association with ErbB2 and correlates with enhanced Erk1/2 phosphorylation.